Medtronic has a long-standing commitment to delivering innovative pain stimulation technology and building the evidence that matters today and leads us into the future.
This is again one of those times. Meaningful innovation is witnessed when new technology fundamentally changes the way you and your patients evaluate the therapeutic treatment and interact with a device. Other times, innovation is judged by what it reduces or may eliminate for treatment such as time, repeat surgical intervention or subjective feedback. Innovation that changes the way you consider treatment options, trial and implant procedures, and ongoing therapy management, is meaningful.
This educational supplement looks at the products, therapy and evidence that has influenced Medtronic’s entire pain stimulation platform and is changing the conversation to a new way of thinking about pain stimulation as an option for your patients.
[pdfviewer width=”100%” height=”940px” beta=”true”]https://neuronewsinternational.com/wp-content/uploads/sites/3/2018/02/NeuroNews-Medtronic-educational-supplement-Jan18.pdf[/pdfviewer]
